Document is current
Any future updates will be listed below
-
Authors
Tang, Shiying https://orcid.org/0000-0002-5095-4158
Che, Xiaofang
Wang, Jinyan
Li, Ce
He, Xin
Hou, Kezuo
Zhang, Xiaojie
Guo, Jia
Yang, Bowen
Li, Danni
Cao, Lili
Qu, Xiujuan
Wang, Zhenning https://orcid.org/0000-0003-0557-3097
Liu, Yunpeng https://orcid.org/0000-0002-9645-7990
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81972751)
National Natural Science Foundation of China (32170791)
National Natural Science Foundation of China (81972331)
National Key Research and Development Program of China
Research Project of Education Department of Liaoning Province
Noncommunicable Chronic Diseases-National Science and Technology Major Project
- License Information
-
More Information
Article History
Received: 25 April 2024
Accepted: 4 April 2025
First Online: 25 April 2025
Competing interests
: X.C., X.Q., Y.L., and S.T. declare a pending patent (P012510580) regarding T-bet+ CD8 + T cells as a therapeutic biomarker in GI cancers. The remaining authors declare no competing interests.
